e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Pulmonary circulation: clinical science and treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Serum levels of microRNA-125a are decreased in patients with precapillary pulmonary hypertension and correlate inversely with hemodynamics
L. Huber, S. Ulrich, M. Gassmann, U. Treder, R. Speich, M. Brock (Zurich, Switzerland)
Source:
Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Session:
Pulmonary circulation: clinical science and treatment
Session type:
Poster Discussion
Number:
3416
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Huber, S. Ulrich, M. Gassmann, U. Treder, R. Speich, M. Brock (Zurich, Switzerland). Serum levels of microRNA-125a are decreased in patients with precapillary pulmonary hypertension and correlate inversely with hemodynamics. Eur Respir J 2013; 42: Suppl. 57, 3416
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Exercise dependence of serum NT-PROBNP levels in patients with precapillary pulmonary hypertension
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009
Serum soluble ST2 and interleukin-33 levels in patients with pulmonary arterial hypertension and their relationship with right ventricular structure and function
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013
Analysis of pulmonary endothelial microparticles, haemodynamics and functional class in pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015
Is the increase in NO lung transfer due to free plasmatic hemoglobin in pulmonary arterial hypertension?
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015
Peripheral arterial stiffness and endothelial dysfunction in pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load
Year: 2015
Association of haemodynamic parameters with circulating natriuretic peptides in precapillary pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load
Year: 2015
Changes in red blood cell membrane structure in pulmonary arterial hypertension
Source: International Congress 2016 – Clinic of pulmonary hypertension
Year: 2016
Sildenafil improves heart rate variability, pulmonary hemodynamics and functional status in pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014
Pulmonary arterial hypertension associated with sarcoidosis (BBS-PAH): mechanisms, hemodynamics and prognosis
Source: Eur Respir J 2002; 20: Suppl. 38, 371s
Year: 2002
Unique characteristics of patients with pulmonary arterial hypertension associated with congenital heart disease compared to the rest of pulmonary arterial hypertension subgroups
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014
Apelin improves cardiac output in patients with pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights
Year: 2015
Baseline hemodynamic predictors of treatment response in pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013
The different nature of pulmonary vascular resistant and compliance in reduced and preserved ejection fraction heart failure and associated pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: right ventricular function, exercise and gas exchange
Year: 2014
Muscle function and physical activity in patients with idiopathic pulmonary arterial hypertension (IPAH)
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014
Female pulmonary arterial hypertension is associated with decreased microRNA96 expression
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014
Pulmonary vascular reactivity in pulmonary hypertension due to left heart disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013
Pulmonary Function and response to treatment in pulmonary arterial hypertension (PAH)
Source: International Congress 2016 – Pulmonary hypertension: the clinic II
Year: 2016
Prognostic role of serum bilirubin levels in pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016
Specific pulmonary arterial hypertension therapy in COPD patients with severe pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
Assessment of platelet dysfunction in patients with pulmonary arterial hypertension
Source: International Congress 2016 – Pulmonary hypertension: the clinic I
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept